Nasdaq rises over 100 points as Jabil posts upbeat Q4 earnings
- Nasdaq Composite rose 0.48% to 26,926.89, gaining over 100 points
- Jabil Inc. reported Q4 EPS of $4.40, beating consensus estimate of $4.06
- Jabil Q4 sales hit $10.616 billion, exceeding the $9.693 billion forecast
- Core PCE inflation slowed to 3.0% annually, below the 3.3% expectation
- Jabil guides FY27 sales to $44.500 billion, above market estimates of $42.643 billion

*this image is generated using AI for illustrative purposes only.
U.S. stocks traded higher on Wednesday, with the Nasdaq Composite gaining over 100 points. The index rose 0.48% to 26,926.89, supported by a 0.9% jump in information technology shares.
Jabil Inc. (NYSE: JBL) reported fourth-quarter results that exceeded analyst expectations. The company posted earnings of $4.40 per share, beating the consensus estimate of $4.06. Quarterly sales reached $10.616 billion, surpassing the projected $9.693 billion.
Market performance and sector trends
The broader market showed modest gains alongside the tech-led rally. The Dow Jones Industrial Average edged up 0.09% to 51,398.68, while the S&P 500 rose 0.27% to 7,691.35. Real estate stocks lagged, falling 0.6%.
| Index | Change | Level |
|---|---|---|
| Nasdaq Composite | +0.48% | 26,926.89 |
| S&P 500 | +0.27% | 7,691.35 |
| Dow Jones Industrial Average | +0.09% | 51,398.68 |
Jabil earnings and guidance
Jabil’s strong performance extended beyond the immediate quarter, with robust forward guidance. The company forecasts fiscal year 2027 adjusted earnings per share of $17.55, above market estimates of $16.80. Projected sales for FY27 stand at $44.500 billion, compared to expectations of $42.643 billion.
What the numbers show
The divergence between Jabil’s actual quarterly sales of $10.616 billion and its FY27 annualized projection of $44.500 billion suggests management anticipates sustained growth over the next two years rather than a one-time spike. The beat in both current EPS and future revenue guidance indicates confidence in long-term demand visibility, particularly within the technology sector which led market gains.
Key movers and commodities
Several small-cap stocks saw significant volatility. NewGenIvf Group Ltd (NASDAQ: NIVF) shares jumped 201% to $0.22 after pricing a public offering. Connect Biopharma Holdings Ltd (NASDAQ: CNTB) surged 66% to $1.64 on positive Phase 2 study data. Conversely, Darkiris Inc. (NASDAQ: DKI) fell 39% to $1.5550 following a business update, and Rafael Holdings Inc (NYSE: RFL) dropped 34% to $1.34 after Phase 3 study results.
Commodity markets also advanced. Oil rose 1.1% to $90.37, while gold climbed 1.5% to $4,241.00. Silver gained 0.7% to $61.550, and copper increased 0.6% to $6.6425.
Economic indicators
Recent U.S. economic data presented a mixed but generally favorable picture for inflation and growth. Headline PCE inflation held at 3.4% annually, matching July’s revised reading. Core PCE, excluding food and energy, slowed to 3.0% from 3.3%, coming in below the 3.3% consensus. Second-quarter GDP growth was revised up to 2.2% from 1.5%. However, the U.S. goods trade deficit widened to $132.6 billion in August from $118.9 billion in July.
How might Jabil's aggressive FY27 guidance influence valuation multiples across the broader electronic manufacturing services sector?
Will the divergence between slowing core PCE inflation and the widening goods trade deficit alter the Federal Reserve's rate-cutting trajectory in upcoming meetings?
Can the Nasdaq's tech-led rally sustain momentum if real estate and other cyclical sectors continue to underperform?

























